Urogen Pharma Ltd (URGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Sales | 23,530 | 20,852 | 21,139 | 17,192 | 18,092 |
| Cost of Goods | 2,286 | 2,367 | 2,443 | 2,265 | 2,263 |
| Gross Profit | 21,244 | 18,485 | 18,696 | 14,927 | 15,829 |
| Operating Expenses | 36,139 | 32,352 | 34,521 | 37,237 | 36,374 |
| Operating Income | -14,609 | -13,500 | -15,382 | -22,045 | -20,282 |
| Interest Expense | 3,586 | 3,815 | 3,761 | 3,553 | 3,223 |
| Other Income | -3,967 | -4,573 | -4,939 | -4,594 | -4,675 |
| Pre-tax Income | -22,162 | -21,888 | -24,082 | -30,192 | -28,180 |
| Income Tax | 3,854 | -9 | 54 | 21 | 689 |
| Net Income Continuous | -26,016 | -21,879 | -24,136 | -30,213 | -28,869 |
| Net Income | $-26,016 | $-21,879 | $-24,136 | $-30,213 | $-28,869 |
| EPS Basic Total Ops | -0.54 | -0.68 | -1.03 | -1.30 | -1.25 |
| EPS Basic Continuous Ops | -0.54 | -0.68 | -1.03 | -1.30 | -1.25 |
| EPS Diluted Total Ops | -0.54 | -0.68 | -1.03 | -1.30 | -1.25 |
| EPS Diluted Continuous Ops | -0.54 | -0.68 | -1.03 | -1.30 | -1.25 |
| EBITDA(a) | $-14,831 | $-13,272 | $-15,483 | $-22,182 | $-20,451 |